BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 9, 2015
View Archived Issues
Endonovo Therapeutics announces new bioelectronic-based platforms for regenerative medicine
Read More
Meiji Seika begins two new clinical trials of safinamide for Parkinson's disease
Read More
CEVEC and CellGenix establish collaboration and license agreement for CAPGo technology
Read More
Horizon Discovery and Servier enter agreement on anticancer kinase inhibitors
Read More
Samumed reports DYRK1A inhibitors
Read More
Lion Biotechnologies obtains license from NIH to TIL therapy in additional indications
Read More
Genocea reports durability data from 6-month analysis of phase II GEN-003 trial
Read More
Mixed Hantaan/Puumala virus DNA vaccine shows safety and immunogenicity
Read More
Indoximod/ipilimumab combination therapy well tolerated in phase Ib study
Read More
Novel multiple ligand trap increases muscle and bone mass
Read More
Antibe Therapeutics to move into regenerative medicine through Citagenix acquisition
Read More
Lilly's abemaciclib receives FDA breakthrough therapy designation
Read More
CMV vaccine elicits humoral and cellular immune responses in animal models
Read More
Neurocrine reports data from phase III Kinect 3 study of NBI-98854
Read More
Charles River Laboratories announces three discovery collaborations
Read More
Bristol-Myers Squibb discloses NS5B inhibitors
Read More
Boehringer Ingelheim reports phase II data for BI-655066 in psoriasis
Read More
Capella Therapeutics announces EGFR inhibitors
Read More
Bayer patents Wnt signaling inhibitors
Read More
Prothena presents anti-LAMA4 MAbs
Read More
Cell culture-derived influenza vaccine shows excellent immunogenicity
Read More
FDA grants 12-year exclusivity to Salix and Pharming's Ruconest
Read More
City of Hope receives NIDDK grant to study epigenetic changes in diabetes
Read More
ECTRIMS 2015: MEDI-551 is safe in multiple sclerosis patients; phase I results
Read More
Altor receives NCI grant to support development of ALT-803 for NHL
Read More
Abcam launches anti-PD-L1 antibody research tool
Read More
NIH awards grant to Circulomics to advance Nanobind nucleic acid extraction technology
Read More